baber/WOPTO huggingface dataset:
Patent AU-2010224172-A1 (AU)
Title: Treatment methods for autoimmune disorders
Inventor: ANNE MURRAY LYNNE
IPC: A61K35/12
Filed: 2010-03-10
Abstract: The present invention provides methods and compositions for expanding T regulatory cells ex vivo or in vivo using one or more SAP agonists. The methods and compositions are useful in the treatment of autoimmune diseases and in preventing foreign graft rejection.
Patent AU-2010232448-A1 (AU)
Title: Micro-fabricated catheter and guidewire devices
Inventor: SNYDER EDWARD J
IPC: A61M25/09
Filed: 2010-04-02
Abstract: The present invention relates to catheter and guidewire devices and embodiments thereof. In particular, the present invention relates to catheter and guidewire devices further including embodiments directed to devices having elastomer laminate layers, and formed from hybrid materials. In an exemplary embodiment, a catheter device comprising: a micro-fabricated elongated outer member having an outer surface and an interior surface forming a lumen extending from a proximal end to a distal end and a plurality of fenestrations made through said outer surface and said interior surface into at least a portion of said lumen; and an outer elastomer laminate layer in contact with at least a portion of said outer surface and filling said plurality of fenestrations is provided.
Patent AU-2010232594-A1 (AU)
Title: Inflatable device with fluid controller and self-sealing valve
Inventor: CHAFFEE ROBERT B
IPC: A47C27/08
Filed: 2010-04-01
Abstract: A self-sealing valve comprises a valve housing having a fluid conduit, a valve seat, and a retaining member, the valve housing being configured to pass fluid through the fluid conduit, and a flexible diaphragm comprising a flexible material having resiliency, wherein the retaining member and the flexible diaphragm are configured so that the retaining member retains a portion of the flexible diaphragm so as to use the resiliency of the flexible material to bias the flexible diaphragm against the valve seat to a closed position of the self-sealing valve to provide a self- seal of the fluid conduit, and to facilitate movement of the flexible diaphragm under a fluid bias against a first side of the flexible diaphragm in a first direction away from the valve seat to an open position, and wherein the retaining member and the flexible diaphragm are configured so that the self-sealing valve can be contacted to move a portion of the flexible diaphragm away from the valve seat to the open position.
Patent AU-2010239088-A1 (AU)
Title: A lock assembly
Inventor: JAMES BUTT SIMON
IPC: E05B31/00
Filed: 2010-04-27
Abstract: The present invention relates to a lock assembly which includes a lock body. The lock body is adapted to receive a lock barrel. The lock barrel has a plurality of passages. Each of the passages is in communication at one end with the lock body and open at the other end. The lock assembly also includes at least one wafer and a lower pin part. The wafer is received in one of the passages. The lower pin part is received in at least one of the remainder of the passages. The wafer has a column. One end of the column is adapted to include a key engaging surface whilst the other end is adapted to rest on a wall of the lock body. The lock barrel has a key slot which is in communication with the passages. The key slot is adapted to receive a key with a low cut adapted to correspond to the key engaging surface. The column is so configured as to provide a gap between the key engaging surface and the low cut when the key is a bump key.
Patent AU-2010260539-A1 (AU)
Title: Handheld device for dispensing fluids
Inventor: KNOPOW JEREMY F
IPC: B05B11/00
Filed: 2010-06-17
Abstract: A device 10 for selectively dispensing ones of multiple fluids, preferably cleaning agents, is disclosed. The device includes a reservoir 50 that holds a diluent "D" therein and a housing 20 that includes a main body segment 22 and a head segment 26. A container assembly 100 may be held between the main body and head segments 22, 26. The container assembly may include at least one container body 105, 110, 112, 114, 116. Each container body 105, 110, 112, 114, 116 houses a concentrate "C", for example, a concentrated form of a cleaning or other agent therein. The diluent "D" and concentrates "C" are kept separate from each other, whereby no end use product is stored in the device 10. Instead, end use product is mixed on demand during dispensation.
Patent AU-2010279674-A1 (AU)
Title: Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
Inventor: CHENG HENG
IPC: A61K47/48
Filed: 2010-08-02
Abstract: Antiproliferative compounds having a structure represented by formula (II), where n, R, R, R, R, and R are as defined herein, can be used to treat tumors, optionally when conjugated to a ligand such as an antibody:
Patent AU-2010282784-A1 (AU)
Title: Methods and apparatus for ascertaining interferents and physical dimensions in liquid samples and containers to be analyzed by a clinical analyzer
Inventor: MILLER KERRY L
IPC: G01N21/00
Filed: 2010-08-05
Abstract: A method of inspecting a clinical specimen for a presence of one or more interferents, such as those that might be found within clinical analytical blood specimens by subjecting the specimen to centrifugation to separate the specimen into a red blood cell portion and a blood serum or plasma portion is provided. Subsequent to the centrifuging procedure, the serum or plasma portion of the clinical analytical specimen may be tested for the presence of one or more interferents such as hemolysis, icterus, lipemia, or liquid nonuniformities therein. Additionally, physical dimensional characteristics of the sample container and/or specimen may be determined. Apparatus for carrying out the method are described, as are other aspects.
Patent AU-2010294186-A1 (AU)
Title: Highly concentrated pharmaceutical formulations comprising anti - CD20 antibody
Inventor: ADLER MICHAEL
IPC: A61K9/00
Filed: 2010-09-10
Abstract: The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-CD20 antibody, such as e.g. Rituximab, Ocrelizumab or HuMab<CD20>, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present invention relates to formulations comprising, in addition to a suitable amount of the anti-CD20 antibody, an effective amount of at least one hyaluronidase enzyme as a combined formulation or for use in form of a co-formulation. The said formulations comprise additionally at least one buffering agent, such as e.g. a histidine buffer, a stabilizer or a mixture of two or more stabilizers (e.g. a saccharide, such as e.g. α,α-trehalose dihydrate or sucrose, and optionally methionine as a second stabilizer), a nonionic surfactant and an effective amount of at least one hyaluronidase enzyme. Methods for preparing such formulations and their uses thereof are also provided.
Patent AU-2010306576-A1 (AU)
Title: Treatment of suicidal ideation or behavior using inhibitors of nicotinic acetylcholine receptors
Inventor: SHEEHAN DAVID V
IPC: A61K33/14
Filed: 2010-10-15
Abstract: The invention concerns methods of treating suicidal ideation or behavior in a subject in need thereof, comprising decreasing endogenous nicotinic acetylcholine receptor (nAChR) activity in the subject; therapeutic packages for treating suicidal ideation or behavior; and methods for determining the efficacy of a treatment for suicidal ideation or behavior. In some embodiments, the treatment methods comprise administering to the subject an effective amount of an inhibitor of a nAChR, such as a lithium compound, mecamylamine, clozapine, or asenapine.
Patent AU-2010309706-A1 (AU)
Title: Method, system and computer program for obtaining the transformation of an image
Inventor: DE LOS AIRES ALVAREZ XAVIER
IPC: H04N5/262
Filed: 2010-10-19
Abstract: The invention relates to a system for obtaining the transformation (30) of an image, said system comprising means for capturing image proportions; means for capturing the width of the transformation; means for capturing the height of the virtual representation of the image; means for establishing coordinate axes at the point on the surface, onto which the viewing point is orthogonally projected; means for obtaining a first transformation angle (α) from two parameters: the distance between the point on the surface onto which the viewing point is projected and the upper end furthest from the transformation; and the distance corresponding to the coordinate of the upper end furthest from the transformation in relation to said viewing point, and the distance corresponding to the coordinate of the upper end furthest from the transformation in relation to the viewing point; means for obtaining the lateral transformation longitude (L3) from the first transformation angle and the transformation width; means for obtaining the longitude (L4) of the transformation (30) from the captured proportions and height of the virtual representation; means for obtaining a second transformation angle (λ) from two parameters: the distance between the point on the surface onto which the viewing point is projected and the lower end closest to the transformation; and the distance corresponding to the coordinate of the lower end closest to the transformation.
Patent AU-2010309832-A1 (AU)
Title: Compounds
Inventor: KING-UNDERWOOD JOHN
IPC: A61P35/00
Filed: 2010-10-19
Abstract: The present invention relates to compounds of formula (I) and to compositions comprising the same and to the use of the compounds and their 10 compositions in treatment, for example in the treatment of inflammatory diseases, in particular respiratory inflammatory disease. The invention also extends to methods of making said compounds.
Patent AU-2010309968-A1 (AU)
Title: Dye polymers
Inventor: BATCHELOR STEPHEN NORMAN
IPC: C11D3/37
Filed: 2010-10-12
Abstract: The present invention relates to polymeric shading dye and their use in laundry applications. The polymers are polyethylene imines and the dyes are reactive dyes.
Patent AU-2010328682-A1 (AU)
Title: Inorganic phosphate corrosion resistant coatings
Inventor: WAGH ARUN S
IPC: C23C22/78
Filed: 2010-08-20
Abstract: This disclosure relates to phosphate coatings that inhibit corrosion of metals, specifically coatings comprising acidic phosphate and alkaline metal oxide/hydroxide components. In one particular embodiment, phosphate-based coating formulations that reduce or eliminate corrosion of steel and other metals are disclosed. In other embodiments, methods for coating steel surfaces with acidic phosphate and alkaline metal oxide/hydroxide components to reduce or eliminate corrosion of the metal surfaces are disclosed.
Patent AU-2010336955-A1 (AU)
Title: Hard and crunchy confectionary coating
Inventor: HASELEU ANDREA
IPC: A23G3/54
Filed: 2010-12-22
Abstract: A confectionary product has a confectionery center coated with a hard and crunchy confectionary coating formed from rapid crystallizing saccharide, a viscosity increasing agent, and a film forming agent.
Patent WO-2011156847-A1 (WO)
Title: Dispositif microfluidique pour analyse génétique et mitochondriale d'un échantillon biologique
Inventor: SILVERBROOK KIA
IPC: B81B7/02
Filed: 2011-06-01
Abstract: La présente invention concerne un dispositif microfluidique destiné à l'analyse de l'ADN génétique et de l'ADN mitochondrial dans un échantillon. Le dispositif microfluidique comprend une entrée destinée à recevoir un échantillon de matériel biologique comportant des cellules possédant une membrane cellulaire externe qui contient des mitochondries et un noyau, les mitochondries présentant une membrane mitochondriale renfermant de l'ADN mitochondrial et les noyaux présentant une membrane nucléaire renfermant de l'ADN nucléaire; une première section de lyse destinée à la lyse de la membrane cellulaire externe et de la membrane mitochondriale tandis que la membrane nucléaire reste intacte; une seconde section de lyse destinée à la lyse de la membrane nucléaire; des sondes mitochondriales situées en aval de la première section de lyse destinées à l'hybridation avec des séquences d'acide nucléique cibles dans l'ADN mitochondrial pour former des hybrides sonde-cible et des sondes nucléaires situées en aval de la seconde section de lyse destinées à l'hybridation avec des séquences d'acide nucléique cibles dans l'ADN nucléaire pour former des hybrides sonde-cible.
Patent AU-2011202558-A1 (AU)
Title: Method for producing a compound of interest in a filamentous fungal cell
Inventor: HEIN STAM
IPC: C12N9/20
Filed: 2011-06-01
Abstract: Abstract The invention relates to a nucleotide sequence comprising: a synonymous nucleotide coding sequence with optimized codon frequency such that a native codon has been exchanged with a synonymous codon, sajd synonymous codon encoding the same amino acid as the native codon and having a higher frequency in codon usage as defined in Table 1 than the native codon; and optionally said nucleotide sequence comprises control sequences such as: one translational termination sequence orientated in 5' towards 3' direction selected from the following list of sequences: TAAG, TAGA and TAAA, preferably TAAA, and/or one translational initiator coding sequence orientated in 5' towards 3' direction selected from the following list of sequences: gctnccyyc, using ambiguity codes for nucleotides: v (A/C/G); n (AIC/Gft), preferably 5'-GCT TCC TTC-3'. The invention further relates to a consensus hanslational initiator sequence: 5'-mwChkyCAmv-3', preferably the translational initiator sequence is selected from the list consisting of: 51mwChkyCAAA-3', 5' mwChkyCACA-3', and 5'-mwChkyCAAG-3'.
Patent AU-2011207272-A1 (AU)
Title: Crosslinkable thermoplastic polyurethane
Inventor: MAKAL UMIT G
IPC: C08G18/68
Filed: 2011-01-21
Abstract: The TPU of this invention contains unsaturation in its polymeric backbone. The unsaturation can be present in the soft segment or in the hard segment or in both the soft and hard segments of the TPU. The TPU can be molded like a thermoplastic, and can be subsequently crosslinked. In one embodiment, the TPUs of this invention are the reaction product (1) a hydroxyl terminated intermediate, (2) a polyisocyanate, (3) a saturated glycol chain extender, and (4) a glycol chain extender containing carbon-carbon double bonds. In another embodiment of this invention, the thermoplastic polyurethane which is crosslinkable by e-beam irradiation is comprised of the reaction product of (1) a saturated hydroxyl terminated intermediate, (2) an unsaturated hydroxyl terminated intermediate, wherein the unsaturated hydroxyl terminated intermediate contains carbon-carbon double bonds, (3) a polyisocyanate, and (4) a saturated glycol chain extender.
Patent AU-2011211349-A1 (AU)
Title: Shield for use During Baby Burping
Inventor: MCCONAGHY RIKI KIM
IPC: A41D1/215
Filed: 2011-08-09
Abstract: Abstract A wearable burping shield has a torso portion and an over-shoulder portion. The over-shoulder portion comprises a layered construction having an outer moisture absorbent layer, and a second waterproof layer. Together the torso portion and over-shoulder portion define an armhole for receiving an arm therethrough so that the shield may be readily worn while holding an infant. 1 5 3 16 25 19 13 9 11 15 17 23 7 21
Patent AU-2011224220-A1 (AU)
Title: Maternal sialic acid supplementation
Inventor: ZIMMER JOHN PAUL
IPC: A23L33/00
Filed: 2011-03-11
Abstract: The invention provides methods and compositions for improving fetal and child health and development through nutritional supplementation with, for example, sialic acid. Sialic acid can be provided to a female before, during and/or after pregnancy to improve the health and development of a fetus and/or child. The sialic acid can be in a variety of forms in the supplements.
Patent AU-2011226863-A1 (AU)
Title: Regeneration and repair of neural tissue using postpartum-derived cells
Inventor: SANJAY MISTRY
IPC: C12N5/073
Filed: 2011-09-26
Abstract: Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived cells are also disclosed.
Patent AU-2011231173-A1 (AU)
Title: Transdermal administration of peptides
Inventor: DEASY PATRICK BERNARD
IPC: A61K9/00
Filed: 2011-03-23
Abstract: The present invention relates to a method of increasing the bioavailability of a peptide. The method includes altering the lipophilicity of a peptide by the creation of fatty acid peptide salts of the peptide. The fatty acid peptide salts exhibit increased transdermal and transmucosal permeability.
Patent AU-2011237629-A1 (AU)
Title: Glycomimetic compounds and methods to inhibit infection by HIV
Inventor: MAGNANI JOHN L
IPC: A61P31/18
Filed: 2011-04-06
Abstract: Compounds, compositions and methods are provided for use to inhibit infection by human immunodeficiency virus (HIV). More specifically, the present invention relates to glycomimetic compounds that inhibit HIV infection, and uses thereof.
Patent AU-2011238413-A1 (AU)
Title: Spinal traction device
Inventor: BOVELL NICHOLAS JOHN
IPC: A61F5/04
Filed: 2011-04-04
Abstract: A spinal traction device (50) comprises a collar (52) adapted to fit snugly around a user's neck, the collar (52) comprising a pair of elongate collar members (56) which respectively pass around both side of the user's neck and provide a grip against the user's neck and posterior jaw. A suspension means (58) is provided for suspending the collar (52) from a secure anchor point above the user's head. In use, when the user wears the collar (52) around their neck, and allows at least part of their body weight to be suspended by the collar (52) from the anchor point, the device (50) can apply traction to the user's spine.
Patent AU-2011249152-A1 (AU)
Title: Clothes treating apparatus and filter technology
Inventor: KIM DONGHYUN
IPC: D06F39/10
Filed: 2011-05-04
Abstract: A clothes treating apparatus includes an accommodating space, an air supply unit, a duct unit and a filter assembly. The accommodating space is configured to receive one or more clothing articles. The air supply unit is configured to supply air to the accommodating space. The duct unit is configured to guide discharge of air from the accommodating space. The filter assembly is positioned to filter air discharged from the accommodating space through the duct unit and includes a housing, a filter positioned in the housing, a substance removal unit and a collection area defined within the housing. The filter positioned in the housing is configured to filter substances from air passing through the filter assembly. The substance removal unit is configured to move substances remaining on a portion of the filter and press the moved substances into the collection area, which is configured to collect removed substances within the housing.
Patent AU-2011278097-A1 (AU)
Title: Apparatus and method for applying a product to skin
Inventor: STAFFORD-NELSON CHRISTOPHER
IPC: B05B3/00
Filed: 2011-04-08
Abstract: An apparatus (100) for applying product to the skin of a person in a booth (10), comprising: an applicator (57) configured to apply the product to the person; a first guide (40) configured to guide movement of an applicator in a first dimension, in order to enable the applicator to apply the product to the person at a plurality of different heights; and a second guide (20) configured to guide movement of the applicator in a second dimension, in order to enable the applicator to apply the product across the width of the person. The apparatus may comprise control circuitry for controlling the applicator in dependence upon the weight of the person.
Patent AU-2011285856-A1 (AU)
Title: Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
Inventor: BROWN ARTHUR M
IPC: A61K31/497
Filed: 2011-08-02
Abstract: Disclosed are pharmaceutical compositions for and methods of preventing or treating acute and/ or chronic cardiac arrhythmias in a mammal, including terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and/ or maintaining normal sinus rhythm, which contain a combination of 1-[2-[(4- fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-[bis(4-fluorophenyl)- methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
Patent AU-2011285918-A1 (AU)
Title: Safety switch for well operations
Inventor: LUDWIG WESLEY N
IPC: H01H35/32
Filed: 2011-08-02
Abstract: A pressure controlled safety switch comprises an electrical switch disposed in a cavity of a mandrel. A bellows assembly is operably engaged with the electrical switch. The bellows assembly is in fluid communication with a fluid surrounding the mandrel such that a pressure in the fluid no less than a predetermined pressure causes the bellows to activate the electrical switch, and a pressure in the fluid less than the predetermined pressure causes the bellows to deactivate the electrical switch.
Patent AU-2011289154-A1 (AU)
Title: Systems and methods for optimizing parameters of orthopaedic procedures
Inventor: MC KINNON BRIAN W
IPC: A61F2/30
Filed: 2011-08-15
Abstract: Systems and methods for optimizing parameters of an orthopaedic procedure for a particular patient, including parameters relating to the anatomic and biomechanic fit of an implant or implant system implanted into the patient's joint. These systems and methods may utilize patient-specific information gathered pre-operatively in conjunction with optimization algorithms to determine an optimal implant design and an optimal position and orientation for implantation of the implant into the particular patient's joint.
Patent AU-2011308629-A1 (AU)
Title: Drug delivery blade and methods for delivering a drug depot to a target site
Inventor: BARNETT PETER J
IPC: A61M37/00
Filed: 2011-09-30
Abstract: A drug delivery blade for delivering a drug depot to a treatment site in a patient is disclosed. The drug delivery blade includes a shaft defining a longitudinal axis of the blade, a lumen that extends longitudinally from a proximal end of the shaft to a distal end of the shaft, a first beveled cut that forms a sharpened tip at the distal end of the shaft, and a flared portion near the distal end of the shaft. The flared portion of the blade includes two radially- extending blade segments having sharpened leading edges that allow the drug delivery blade to cut tissue when the blade is advanced toward a treatment site. Methods of using the drug delivery blade are also disclosed.
Patent AU-2011311326-A1 (AU)
Title: Sour gelled emulsions
Inventor: SIWEK ANDRZEJ
IPC: A61K9/00
Filed: 2011-10-06
Abstract: The invention relates to an orally administrable, sour-tasting chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and comprises at least one physiologically acceptable acid and at least one buffering agent and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester.
Patent AU-2011319006-A1 (AU)
Title: Hydrophilic film formed on a surface of a metal material, hydrophilization treatment agent and hydrophilization treatment method
Inventor: KATAOKA TOSHIHISA
IPC: C09K3/18
Filed: 2011-10-18
Abstract: [Problem] To provide a hydrophilic film that is formed on the surface of a metal material, inhibits the growth of condensation water, and provides mold resistance, and a hydrophilization treatment agent for forming the hydrophilic film. [Solution] The aforementioned problem is solved by: a hydrophilization treatment agent containing one or more types of compounds selected from poorly water-soluble cerium compounds (A); and a hydrophilic film prepared from the hydrophilization treatment agent. Preferably, the poorly water-soluble cerium compounds (A) are one or more compounds selected from cerium (III) carbonate, cerium (III) fluoride, cerium (IV) fluoride, and cerium (IV) oxide. By forming the hydrophilic film on the surface of a metal material, the growth of condensation water can be inhibited and mold resistance can be provided.